|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/436 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Number of the document | 3346989 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15903759.7 |
| Date of filing the European patent application | 2015-09-21 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/051206 |
| Date | 2015-09-21 |
| (87) | Number | WO 2017/044135 |
| Date | 2017-03-16 |
| (30) | Number | Date | Country code |
| 201514849100 | 2015-09-09 | US |
| (72) |
SHI, Zhiwei, US
SU, Shih-horng, US
YU, Ting-bin, US
|
| (73) |
Manli International Ltd.,
39 Chuan Walk, 558445 Singapore,
SG
|
| (54) | STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER |
| STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER |